Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

IMX-150 Cream for Diabetic Neuropathy

ClinicalTrials.gov ID: NCT00641953

Public ClinicalTrials.gov record NCT00641953. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 7:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Phase II, Multi-Center, Double-Blind, Placebo-Controlled, Dose-Response Study of an Aqueous Topical Formulation of Nitroglycerin, IMX-150, in the Treatment of Pain in Diabetic Peripheral Neuropathy of the Feet

Study identification

NCT ID
NCT00641953
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Procris Pharmaceuticals
Industry
Enrollment
155 participants

Conditions and interventions

Interventions

  • IMX-150 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2007
Primary completion
Feb 29, 2008
Completion
Feb 29, 2008
Last update posted
Jun 16, 2008

2007 – 2008

United States locations

U.S. sites
7
U.S. states
2
U.S. cities
7
Facility City State ZIP Site status
Meriden Research Brooksville Florida 34613
Health Awareness Jupiter Florida 33458
International Research Associates, LLC Miami Florida 33156
Peninsula Research Ormond Beach Florida 32174
Alpha Medical Research Oviedo Florida 32765
Meridien Research St. Petersburg Florida 33709
Hampton Roads Center for Clinical Research Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00641953, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 16, 2008 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00641953 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →